Schlaich M - Search Results

1

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice.

Herat L, Rudnicka C, Okada Y, Mochizuki S, Schlaich M, Matthews V. Herat L, et al. Among authors: schlaich m. Int J Mol Sci. 2017 Apr 21;18(4):884. doi: 10.3390/ijms18040884. Int J Mol Sci. 2017. PMID: 28430139 Free PMC article.

2

Is it time to think about the sodium glucose co-transporter 2 sympathetically?

Elliott RH, Matthews VB, Rudnicka C, Schlaich MP. Elliott RH, et al. Nephrology (Carlton). 2016 Apr;21(4):286-94. doi: 10.1111/nep.12620. Nephrology (Carlton). 2016. PMID: 26369359 Review.

3

Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.

Hoyne G, Rudnicka C, Sang QX, Roycik M, Howarth S, Leedman P, Schlaich M, Candy P, Matthews V. Hoyne G, et al. Among authors: schlaich m. BMC Cancer. 2016 Feb 24;16:151. doi: 10.1186/s12885-016-2178-4. BMC Cancer. 2016. PMID: 26912236 Free PMC article.

4

Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.

Rudnicka C, Mochizuki S, Okada Y, McLaughlin C, Leedman PJ, Stuart L, Epis M, Hoyne G, Boulos S, Johnson L, Schlaich M, Matthews V. Rudnicka C, et al. Among authors: schlaich m. Medicine (Baltimore). 2016 Oct;95(40):e5085. doi: 10.1097/MD.0000000000005085. Medicine (Baltimore). 2016. PMID: 27749584 Free PMC article.

5

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Weerasekera L, Rudnicka C, Sang QX, Curran JE, Johnson MP, Moses EK, Göring HH, Blangero J, Hricova J, Schlaich M, Matthews VB. Weerasekera L, et al. Among authors: schlaich m. Mediators Inflamm. 2017;2017:7281986. doi: 10.1155/2017/7281986. Epub 2017 Feb 7. Mediators Inflamm. 2017. PMID: 28265178 Free PMC article.

6

Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2.

Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP. Matthews VB, et al. J Hypertens. 2017 Oct;35(10):2059-2068. doi: 10.1097/HJH.0000000000001434. J Hypertens. 2017. PMID: 28598954

7

The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Carnagarin R, Gregory C, Azzam O, Hillis GS, Schultz C, Watts GF, Bell D, Matthews V, Schlaich MP. Carnagarin R, et al. Curr Hypertens Rep. 2017 Oct 28;19(12):99. doi: 10.1007/s11906-017-0795-1. Curr Hypertens Rep. 2017. PMID: 29080925 Free article. Review.

8

Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.

Saunders BM, Rudnicka C, Filipovska A, Davies S, Ward N, Hricova J, Schlaich MP, Matthews VB. Saunders BM, et al. Among authors: schlaich mp. Immunol Cell Biol. 2018 Jan;96(1):41-53. doi: 10.1111/imcb.1002. Epub 2017 Nov 23. Immunol Cell Biol. 2018. PMID: 29359470

9

Pharmacotherapeutic strategies for treating hypertension in patients with obesity.

Carnagarin R, Matthews V, Gregory C, Schlaich MP. Carnagarin R, et al. Expert Opin Pharmacother. 2018 May;19(7):643-651. doi: 10.1080/14656566.2018.1458092. Epub 2018 Mar 30. Expert Opin Pharmacother. 2018. PMID: 29600880 Review.

10

Suitability for catheter-based renal denervation-lessons from 'super-responders'.

Schlaich MP, Carnagarin R, Ho JK, Matthews VB. Schlaich MP, et al. J Hypertens. 2018 Jul;36(7):1475-1476. doi: 10.1097/HJH.0000000000001756. J Hypertens. 2018. PMID: 29847451 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters